Form 8-K · Current Report · Filed 2026-08-04
Merck Reports Second-Quarter 2026 Financial Results and Key Regulatory Milestones
Merck & Co., Inc. reported second-quarter 2026 financial results, showing total worldwide sales of $16.6 billion, a 5% increase year-over-year. The company highlighted strong performance in oncology, with notable sales growth for KEYTRUDA and WINREVAIR. Merck also announced several regulatory approvals, including the FDA approval of LIPFENDRA for hypercholesterolemia and positive clinical trial results for sacituzumab tirumotecan in endometrial cancer. The company raised its full-year 2026 sales outlook to between $66.3 billion and $67.3 billion, reflecting the impact of the acquisition of Terns.
- Filer
- Merck & Co., Inc. MRK · NYSE
- Filed
- Accession
- 0001104659-26-090045
- CIK
- 0000310158
- Signal
- High impactHealthcare
- Source
- Official filing on sec.gov ↗
Items reported
Reported Item
Market reaction
Close before filing
$130.20
Since filing
+0.0%
Latest close
$130.20
What happened, not what will happen — closing prices around the filing date.
Precedent
Previous filings from MRK reporting the same item, with the next session's move:
Insider tape
Within 45 days of this filing, MRK insiders reported 3 Form 4 transactions — net buying of $54K.
About Merck & Co., Inc.
Merck & Co., Inc. is a prominent player in the global pharmaceutical industry. It is primarily focused on the research, development, production, and marketing of drugs and vaccines. Known for its strong emphasis on innovative health solutions, Merck develops treatments and vaccines for a variety of diseases affecting humans and animals. Key areas include oncology, infectious diseases, diabetes, and vaccines, reflecting its commitment to addressing critical health challenges worldwide. The company operates in several strategic regions, exporting its advanced therapies to meet healthcare needs across different markets. With a robust pipeline of new products and significant investment in research and development, Merck plays a vital role in advancing medical breakthroughs and enhancing patient care. Beyond pharmaceuticals, Merck is involved in animal health, providing veterinary vaccines and services, contributing to agricultural productivity and food security. The company's ongoing efforts in groundbreaking research and public health initiatives underscore its importance in the healthcare sector.
Never miss another MRK filing
Profitelligence watches EDGAR around the clock and alerts you within seconds.